[1]范仰钢,胡尊玲,袁国强.32P-磷酸铬胶体滑膜切除术联合常规药物治疗强直性脊柱炎髋关节病变[J].国际放射医学核医学杂志,2011,35(5):285-288.[doi:10.3760/cma.j.issn.1673-4114.2011.05.008]
　FAN Yang-gang,HU Zun-ling,YUAN Guo-qiang.32P-chromic phosphate colloidal synovectomy combined with routine medication treating the hip disease of ankylosing spondylitis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):285-288.[doi:10.3760/cma.j.issn.1673-4114.2011.05.008]
点击复制

32P-磷酸铬胶体滑膜切除术联合常规药物治疗强直性脊柱炎髋关节病变(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
35
期数:
2011年第5期
页码:
285-288
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
32P-chromic phosphate colloidal synovectomy combined with routine medication treating the hip disease of ankylosing spondylitis
作者:
范仰钢;  胡尊玲;  袁国强
武警上海总队医院风湿科, 上海 201103
Author(s):
FAN Yang-gang;  HU Zun-ling;  YUAN Guo-qiang
Department of Rheumatology, Shanghai Hospital of Armed Police Corps, Shanghai 201103, China
关键词:
脊柱炎; 强直性; 骨关节炎; 髋; 滑膜切除术; 磷放射性同位素; 药物疗法; 磷酸铬胶体
Keywords:
Spondylitis; ankylosing; Osteoarthritis; hip; Phosphorus radioisotopes; Synovectomy; Drug therapy; Chromic phosphate colloid
DOI:
10.3760/cma.j.issn.1673-4114.2011.05.008
摘要:
目的 观察32P-磷酸铬胶体滑膜切除术联合常规药物治疗强直性脊柱炎髋关节病变的疗效。方法 强直性脊柱炎单侧髋关节病变住院患者84例,分别人组常规药物联合32P-磷酸铬胶体滑膜切除术组(联合治疗组)和单用常规药物组(对照组)各42例,观察其疗效和安全性。结果 随访6个月,联合治疗组和对照组有效率分别为73.8%和52.4%,联合治疗组显着优于对照组(χ2=4.840,P<0.05);随访3年,有效率分别为53.8%和47.6%,两组比较无统计学意义(χ2=0.047,P>0.05)。随访3年髋关节X线分期出现进展,联合治疗组与对照组比较差异显着(χ2=5.516,P<0.05).随访6个月及随访3年,联合治疗组和对照组分别与治疗前Bath强直性脊柱炎病情活动指数(BAS-DAI)评分的差值比较,差异均无统计学意义(t=1.303,P>0.05及t=1.759,P>0.05)。随访6个月,联合治疗组和对照组的髋关节视觉模拟评分(VAS)与治疗前的差值比较差异显着(t=2.389,P<0.05),而随访3年,联合治疗组和对照组的髋关节VAS评分与治疗前的差值比较,其差异无统计学意义(t=1.632,P>0.05)。不良反应仅见5例出现一过性关节疼痛加重。结论 32P-磷酸铬胶体滑膜切除术联合常规药物治疗强直性脊柱炎髋关节病变有一定近期疗效。
Abstract:
Objective To observe the therapeutic effect of 32P-chromic phosphate colloidal synovectomy combined with routine medication in the treatment of the hip disease of ankylosing spondylitis. Method Eight-two ankylosing spondylitis unilateral hip patients were divided into two groups. Forty-two were enrolled in the routine medication combined with 32P-chromic phosphate colloidal synovectomy group(treatment group) and 42 in conventional medicine group(control group). The efficacy and safety were observed. Results The effective rate of treatment group and control group were 73.8% and 52.4% respectively in the following six months. The difference was significant(χ2=4.840, P<0.05). The effective rate were respectively 53.8% and 47.6% in three-year follow-up, with no significant difference between the two groups(χ2=0.047, P>0.05). There was progress on the X-ray phases of hip joint in three-year follow-up, for the difference between the treatment group and the control group was significant(χ2=5.516, P <0.05). During the different follow-up time, six months and three years, there were differences in Bath Ankylosing Spondylitis Disease Activity Index(BASDAI) before and after treatment between the treatment group and the control group, but the differences were not statistically significant(t=1.303, t=1.759, P all>0.05). When followed up for 6 months, the differences in the visual analogue scale(VAS) for hip of the treatment group and the control group were statistically different between before and after treatment(t=2.389, P<0.05). But when followed up for three years, the differences were not statistically different(t=1.632, P>0.05). The side effects was ob served only in five cases which was transient pain increase in joints. Conclusion 32P-chromic phosphate colloid synovectomy combined with routine medication had a short-term effect in treating the hip joint disease of ankylosing spondylitis.

参考文献/References:

[1] Brophy S,Mackay K,AlSaidi A,et al.The natural history of anky-losing spondylitis as defined by radiological progression.J Rheumatol,2002,29(6):1236-1243.
[2] Brophy S,Calin A.Ankylosing spondylitis:interaction between genes,joints,age at onset,and disease expression.J Rheumatol,2001.28(10):2151-2154.
[3] Silva M,Luck JR,Siegel ME.32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis.Haemophilia,2001,7 Suppl 2:40-49
[4] 李兴福,王淑贞,王韶进,等.胶体磷酸铬32P放射性滑膜切除术治疗类风湿膝关节炎(附85例报告).山东医药,2002,42(18):3-5.
[5] 范仰钢,李国华,李光明.32P-磷酸铬胶体滑膜切除术治疗色素沉着绒毛结节性滑膜炎.中华骨科杂志,2006.26(8):569-570.
[6] Deutsch E,Brodack JW,Deutsch KF.Radiation synovectomy reviisited.Eur J Nucl Med,1993,20(11):1113-1127.
[7] 赵福涛,管剑龙,韩星海.甲氨蝶呤治疗强直性脊柱炎髋关节病变的临床研究.中华风湿病学杂志,2007,11(4):213-216.
[8] Zoching J,D van der Heijde D,Burgos-Vargas R,et al.ASAS/EULAR recommendation for the management of ankylosing spondylitis.Ann Rheum Dis,2006,65(4):442-452.
[9] 韩星海,赵福涛,管剑龙,等.局部X线放射治疗强直性脊柱炎髋关节病变的临床研究中华风湿病学杂志,2005,9(1):8-11.
[10] 伍中庆,苏培基,王海彬,等.强直性脊柱炎致髋关节病变滑膜切除术的意义分析.中国中医骨伤科杂志,2002,10(6):48-49.
[11] Jahangier ZN,Moolenburgh JD,Jacobs JW,et al.The effect of radiation synovectomy in patients with persistent arthritis:a prospective study.Clin Exp Rheumatol,2001,19(4):417-424.
[12] Kampen WU,Brenner W,Kroeger S,et al.Long-term results of radiation synovectomy:a clinical follow-up study.Nucl Med Gommun,2001,22(2):239-246.

相似文献/References:

[1]薛秀青,苏成海.99Tc-亚甲基二膦酸盐的临床应用研究进展[J].国际放射医学核医学杂志,2010,34(5):285.[doi:10.3760/cma.j.issn.1673-4114.2010.05.008]
　XUE Xiu-qing,SU Cheng-hai.Progress of 99Tc-methylenediphosphonate in clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):285.[doi:10.3760/cma.j.issn.1673-4114.2010.05.008]

备注/Memo

备注/Memo:
收稿日期:2011-05-23。
通讯作者:范仰钢(Email:fanyanggang@foxmail.com)
更新日期/Last Update: 1900-01-01